Corrigendum
Corrigendum to “Evaluation of Complication Rates after Breast Surgery Using Acellular Dermal Matrix: Median Follow-Up of Three Years”
Table 4
Overall complication probabilities for used ADMs.
| |||||||||||||||||||||||||||||||||||||||
Short-term (skin necrosis, seroma, haematoma, infection, and Red Breast Syndrome (RBS)) and long-term complications (capsular contracture, implant malposition, and implant loss) for all breasts with usage of ADMs (human ADM (HADM), porcine ADM (PADM), and bovine ADM (BADM)), median follow-up time for all patients, and total complications of all breasts being reconstructed with ADMs; denotes being excluded from overall complications and requiring further medical treatment; denote >Baker-St. II. |